These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 659766)

  • 1. Serum uric acid and the renin-angiotensin system in hypertension.
    Saito I; Saruta T; Kondo K; Nakamura R; Oguro T; Yamagami K; Ozawa Y; Kato E
    J Am Geriatr Soc; 1978 Jun; 26(6):241-7. PubMed ID: 659766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma renin activity, creatinine and uric acid in the serum of patients with essential hypertension].
    Pjescák M; Suchmanová I; Mechír J; Tkácová R; Rajnová E
    Vnitr Lek; 1990 Jan; 36(1):59-63. PubMed ID: 2183472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid and the state of the intrarenal renin-angiotensin system in humans.
    Perlstein TS; Gumieniak O; Hopkins PN; Murphey LJ; Brown NJ; Williams GH; Hollenberg NK; Fisher ND
    Kidney Int; 2004 Oct; 66(4):1465-70. PubMed ID: 15458439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults.
    Mulè G; Castiglia A; Morreale M; Geraci G; Cusumano C; Guarino L; Altieri D; Panzica M; Vaccaro F; Cottone S
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):350-359. PubMed ID: 28274727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 1-sarcosine-8-isoleucine-angiotensin II on blood pressure and plasma renin activity in various types of hypertension.
    Yasujima M; Abe K; Aoyagi H; Irokawa N; Memezawa H
    Tohoku J Exp Med; 1975 Jul; 116(3):277-83. PubMed ID: 1179425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of furosemide administration and upright position on plasma renin activity and angiotensin II in hypertension.
    Fukuchi S; Takenouchi T; Nakajima K
    Tohoku J Exp Med; 1973 Sep; 111(1):71-8. PubMed ID: 4359911
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes of plasma renin, angiotensin II and renin substrate during reversal of malignant renovascular hypertension.
    Schultze G; Oelkers W
    Klin Wochenschr; 1975 Dec; 53(23):1115-9. PubMed ID: 1206969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K; Gregorová I
    Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ; Koopmans RP; van Montfrans GA
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperuricemia and plasma renin activity in essential arterial hypertension].
    Milicević Z; Jelaković B; Marinković M
    Lijec Vjesn; 1994; 116(1-2):14-7. PubMed ID: 8028431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood renin levels in various types of arterial hypertension. Preliminary communication.
    Januszewicz W; Baczko A; Wocial B
    Pol Med J; 1969; 8(1):1-7. PubMed ID: 4305686
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension.
    Tanaka S; Shimamoto K; Takada T; Nakahashi Y; Ando T; Nishitani T; Iimura O
    Jpn J Med; 1985 Feb; 24(1):19-23. PubMed ID: 3889434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of renin profiling in childhood hypertension.
    Gruskin AB; Perlman SA; Baluarte HJ; Polinsky MS; Kaiser BA; Morgenstern BZ
    Clin Exp Hypertens A; 1986; 8(4-5):741-5. PubMed ID: 3530551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin system (second of two parts).
    Oparil S; Haber E
    N Engl J Med; 1974 Aug; 291(9):446-57. PubMed ID: 4367268
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.
    McMullan CJ; Borgi L; Fisher N; Curhan G; Forman J
    Clin J Am Soc Nephrol; 2017 May; 12(5):807-816. PubMed ID: 28320765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of plasma renin activity in patients with hypertension.
    Kokot F; Kuska J; Czekala Z; Kiecoń I
    Pol Med J; 1968; 7(6):1319-27. PubMed ID: 4305122
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma renin activity and urinary aldosterone in Cushing's syndrome.
    Mantero F; Armanini D; Boscaro M
    Horm Metab Res; 1978 Jan; 10(1):65-71. PubMed ID: 204567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.